staurosporine has been researched along with nicardipine in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 5 (71.43) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (28.57) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Calixto, JB; GuimarĂ£es, CL; Rae, GA | 1 |
Eguchi, S; Emori, T; Hirata, Y; Imai, T; Kanno, K; Marumo, F; Ohta, K; Shichiri, M | 1 |
Kitamura, K; Kuriyama, H; Oike, M | 1 |
Harayama, N; Kabashima, N; Nomura, M; Shibuya, I; Tanaka, K; Ueta, Y; Yamashita, H | 1 |
Alexiou, K; Brunner, F; Dschietzig, T; Stangl, K | 1 |
7 other study(ies) available for staurosporine and nicardipine
Article | Year |
---|---|
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Potent constrictor actions of endothelin-1, endothelin-2, and endothelin-3 in rat isolated portal vein.
Topics: Alkaloids; Animals; Benzopyrans; Calcium; Cromakalim; Endothelins; Glyburide; Indomethacin; Male; Mesenteric Veins; Nicardipine; Phorbols; Portal Vein; Protein Kinase C; Pyrroles; Rats; Rats, Inbred Strains; Staurosporine; Vasoconstriction; Vasodilator Agents | 1992 |
Cellular mechanism of endothelin-1 release by angiotensin and vasopressin.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Alkaloids; Angiotensin II; Animals; Arginine Vasopressin; Calcium; Cattle; Cells, Cultured; Diglycerides; Dose-Response Relationship, Drug; Down-Regulation; Egtazic Acid; Endothelins; Endothelium, Vascular; In Vitro Techniques; Inositol 1,4,5-Trisphosphate; Isoquinolines; Neomycin; Nicardipine; Piperazines; Protein Kinase C; Protein Kinase Inhibitors; Staurosporine | 1991 |
Protein kinase C activates the non-selective cation channel in the rabbit portal vein.
Topics: Alkaloids; Animals; Chlorides; GTP-Binding Proteins; Guanosine 5'-O-(3-Thiotriphosphate); In Vitro Techniques; Ion Channels; Male; Muscle, Smooth, Vascular; Nicardipine; Niflumic Acid; Pertussis Toxin; Phorbol 12,13-Dibutyrate; Portal Vein; Protein Kinase C; Rabbits; Staurosporine; Virulence Factors, Bordetella | 1993 |
Pituitary adenylate cyclase-activating polypeptide potentiation of Ca2+ entry via protein kinase C and A pathways in melanotrophs of the pituitary pars intermedia of rats.
Topics: Animals; Barium; Calcium; Calcium Channel Blockers; Calcium Channels; Cells, Cultured; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Diglycerides; Dopamine; Fura-2; In Situ Hybridization; Male; Neuropeptides; Neurotransmitter Agents; Nicardipine; Pituitary Adenylate Cyclase-Activating Polypeptide; Pituitary Gland; Protein Kinase C; Rats; Rats, Wistar; Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide; Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I; Receptors, Pituitary Hormone; RNA, Messenger; Signal Transduction; Staurosporine | 1997 |
Antithrombin increases pulmonary endothelins: inhibition by heparin and Ca2+ channel antagonism.
Topics: Analysis of Variance; Animals; Anticoagulants; Antithrombin III; Calcium Channel Blockers; Drug Interactions; Endothelin-1; Enzyme Inhibitors; Genistein; Heparin; Lung; Male; Nicardipine; Protein Kinase C; Protein-Tyrosine Kinases; Rats; Rats, Wistar; Serine Proteinase Inhibitors; Staurosporine; Up-Regulation | 1999 |